Price to Sales (P/S)
since 2019
Paying user area
Try for free
Shockwave Medical Inc. pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Income Statement
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Net Profit Margin since 2019
- Total Asset Turnover since 2019
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Shockwave Medical Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Shockwave Medical Inc., P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Revenue1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2021 | = | ÷ | = | ÷ | |||||||
| Mar 12, 2020 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Shockwave Medical Inc. Annual Report.
- Share Price
- The share price exhibited significant volatility over the analyzed period. It started at $29 in March 2020, then soared sharply to $116.76 by February 2021, followed by a continued increase to $175.59 in February 2022 and $189.52 in February 2023. The upward trend culminated in a substantial rise to $259.89 by February 2024, indicating strong investor confidence and growth expectations.
- Sales per Share
- Sales per share demonstrated a consistent and pronounced growth throughout the period. Beginning at $1.35 in March 2020, this figure increased to $1.95 in February 2021, then escalated markedly to $6.65 in February 2022. The growth trend accelerated further with sales per share reaching $13.42 in February 2023 and peaking at $19.53 in February 2024. This upward trajectory suggests a substantial improvement in revenue generation per share over time.
- Price-to-Sales Ratio (P/S)
- The price-to-sales ratio started at 21.46 in March 2020 and surged to an elevated high of 60.01 by February 2021. Subsequently, the ratio declined steadily to 26.4 in February 2022 and continued to decrease to 14.12 in February 2023, eventually settling at 13.31 by February 2024. This pattern indicates that while the share price increased, the rate of sales growth outpaced the price appreciation on a relative basis, contributing to a more moderate valuation metric over time.
Comparison to Competitors
Shockwave Medical Inc., P/S, long-term trends, comparison to competitors
| Shockwave Medical Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Feb 26, 2024 | ||||||
| Feb 27, 2023 | ||||||
| Feb 25, 2022 | ||||||
| Feb 26, 2021 | ||||||
| Mar 12, 2020 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Comparison to Sector (Health Care Equipment & Services)
Shockwave Medical Inc., P/S, long-term trends, comparison to sector (health care equipment & services)
| Shockwave Medical Inc. | Health Care Equipment & Services | |
|---|---|---|
| Feb 26, 2024 | ||
| Feb 27, 2023 | ||
| Feb 25, 2022 | ||
| Feb 26, 2021 | ||
| Mar 12, 2020 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Comparison to Industry (Health Care)
Shockwave Medical Inc., P/S, long-term trends, comparison to industry (health care)
| Shockwave Medical Inc. | Health Care | |
|---|---|---|
| Feb 26, 2024 | ||
| Feb 27, 2023 | ||
| Feb 25, 2022 | ||
| Feb 26, 2021 | ||
| Mar 12, 2020 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).